- Conditions
- Skin Diseases, Bacterial
- Interventions
- Intravenous iclaprim, Intravenous linezolid
- Drug
- Lead sponsor
- Arpida AG
- Industry
- Eligibility
- 18 Years to 90 Years
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- Started 2006
- U.S. locations
- 2
- States / cities
- Naperville, Illinois • Casper, Wyoming
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Showing 1–5
of 5
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Skin Structures and Soft Tissue Infections
- Interventions
- iclaprim, vancomycin
- Drug
- Lead sponsor
- Motif Bio
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 600 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 16
- States / cities
- Buena Park, California • La Mesa, California • Long Beach, California + 12 more
- Conditions
- Complicated Skin and Skin Structure Infection
- Interventions
- intravenous iclaprim or intravenous linezolid
- Drug
- Lead sponsor
- Arpida AG
- Industry
- Eligibility
- 18 Years and older
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2005 – 2006
- U.S. locations
- 5
- States / cities
- National City, California • Boise, Idaho • Indianapolis, Indiana + 2 more
- Conditions
- Skin Structures and Soft Tissue Infections
- Interventions
- Iclaprim, Vancomycin
- Drug
- Lead sponsor
- Motif Bio
- Industry
- Eligibility
- 18 Years and older
- Enrollment
- 613 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2015 – 2017
- U.S. locations
- 17
- States / cities
- Anaheim, California • Buena Park, California • Chula Vista, California + 12 more
- Conditions
- Prostate Cancer
- Interventions
- Degarelix, pTVG-AR, Nivolumab, Cemiplimab, Fianlimab, FLT PET/CT
- Drug · Biological
- Lead sponsor
- University of Wisconsin, Madison
- Other
- Eligibility
- 18 Years and older · Male only
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2021 – 2028
- U.S. locations
- 1
- States / cities
- Madison, Wisconsin